). It was observed that salicylate MBIs could maintain or improve enzyme inhibition and selectivity. To probe salicylate MBIs as fragments for fragment-based drug discovery (FBDD), an MBI that showed good inhibitory activity against GLO1 was derivatized and a rudimentary structure-activity relationship was developed. The resulting elaborated fragments showed GLO1 inhibition with low micromolar activity.
No takes yet. Share an insight, caveat, or question.
Jackl et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: